Yuanhe Capital
Overview
Yuanhe Capital is a value-investing equity investment fund management company that focuses on opportunities in new energy, new materials, biomedicine, intelligent manufacturing, military and aerospace, and information technology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Beijing Inspire-Robots Technology Co., Ltd. | Apr 2025 | Series B Extension | Co-investor |
| Nanjing Shineking Biotech Co., Ltd. | Sep 2021 | Series B Extension | Co-investor |
| RealMan Robotics | May 2023 | Series A Extension | Co-investor |
| Grit Biotherapeutics | Sep 2023 | Series B | Co-investor |
| Shanghai StairMed Technology Co., Ltd. | Dec 2022 | Series A | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Yuanhe Capital based?
Yuanhe Capital is headquartered in Yantai, China.
When was Yuanhe Capital founded?
Yuanhe Capital was founded in 2019.
How many portfolio companies does Yuanhe Capital have?
Yuanhe Capital has 6 portfolio companies in Caplight's dataset.
What are some companies in Yuanhe Capital's portfolio?
Portfolio companies visible on Caplight include Beijing Inspire-Robots Technology Co., Ltd., Nanjing Shineking Biotech Co., Ltd., RealMan Robotics, Grit Biotherapeutics, Shanghai StairMed Technology Co., Ltd..
What was Yuanhe Capital's most recent investment shown here?
Yuanhe Capital's most recent investment in this portfolio sample was in Beijing Inspire-Robots Technology Co., Ltd. in 2025.
What sectors does Yuanhe Capital focus on?
Yuanhe Capital focuses on Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences.
What company stages does Yuanhe Capital focus on?
Yuanhe Capital typically invests at the Early stage.
What is Yuanhe Capital's AUM?
Yuanhe Capital's assets under management are estimated at over $18.2B.